- Home
- LSTA vs LRE Comparison
LSTA vs LRE Comparison
Compare LSTA & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- LRE
- Stock Information
- Founded
- LSTA 1980
- LRE 2001
- Country
- LSTA United States
- LRE Japan
- Employees
- LSTA N/A
- LRE N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- LRE
- Sector
- LSTA Health Care
- LRE
- Exchange
- LSTA Nasdaq
- LRE Nasdaq
- Market Cap
- LSTA 20.9M
- LRE 20.5M
- IPO Year
- LSTA N/A
- LRE 2023
- Fundamental
- Price
- LSTA $2.52
- LRE $1.64
- Analyst Decision
- LSTA Strong Buy
- LRE
- Analyst Count
- LSTA 2
- LRE 0
- Target Price
- LSTA $23.50
- LRE N/A
- AVG Volume (30 Days)
- LSTA 23.5K
- LRE 2.5M
- Earning Date
- LSTA 11-11-2025
- LRE 01-01-0001
- Dividend Yield
- LSTA N/A
- LRE N/A
- EPS Growth
- LSTA N/A
- LRE N/A
- EPS
- LSTA N/A
- LRE N/A
- Revenue
- LSTA $1,070,000.00
- LRE $110,330,328.00
- Revenue This Year
- LSTA N/A
- LRE N/A
- Revenue Next Year
- LSTA N/A
- LRE N/A
- P/E Ratio
- LSTA N/A
- LRE N/A
- Revenue Growth
- LSTA N/A
- LRE 3.92
- 52 Week Low
- LSTA $1.87
- LRE $1.00
- 52 Week High
- LSTA $4.20
- LRE $2.97
- Technical
- Relative Strength Index (RSI)
- LSTA 54.15
- LRE 50.45
- Support Level
- LSTA $2.36
- LRE $1.46
- Resistance Level
- LSTA $2.62
- LRE $1.77
- Average True Range (ATR)
- LSTA 0.18
- LRE 0.19
- MACD
- LSTA 0.03
- LRE -0.01
- Stochastic Oscillator
- LSTA 72.08
- LRE 32.39
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.